Brief: Noxopharm Ltd Says Unit Entered Into A Licence Agreement With Hudson Institute Of Medical Research
17/11/2021 01:30
Nov 17 (Reuters) - Noxopharm Ltd NOX.AX :
* UNIT ENTERED INTO A LICENCE AGREEMENT WITH HUDSON
INSTITUTE OF
MEDICAL RESEARCH
* LICENCING DEAL TO LIMIT SIDE-EFFECTS OF RNA THERAPEUTICS
Source text for Eikon: ID:nASX2y3K1x
Further company coverage: NOX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Noxopharm
See all newsBrief: Noxopharm Announces SOF-SKN Manufacturing Begins To Ensure Clinical Trial Readiness
Australia's Noxopharm rises as novel cancer therapy shows potential
Brief: Noxopharm Says New Data Confirms Cancer-Fighting Potential
Brief: Noxopharm Appoints Dr Olivier Laczka As New CEO
Brief: Noxopharm Ltd Announces Resignation Of Chief Executive Officer